Keyphrases
Cell-based
100%
Prostate Cancer
100%
CD40
100%
Dendritic Cells
100%
Prostate-specific Antigen
100%
Adenovirus Vector
100%
RM-1
55%
Antigen Presentation
22%
Human Prostate
22%
Protein Expression
11%
Mouse Model
11%
Prostate Cancer Cell Lines
11%
Tumor Antigen
11%
T Cells
11%
Adenovirus
11%
Interferon-γ
11%
Intraperitoneal Injection
11%
Prostate Tumor
11%
Clinical Utility
11%
Gene Therapy Trials
11%
Cancer Immunotherapy
11%
Ad Vector
11%
Tumor-specific
11%
MHC Class I
11%
Antitumor Efficacy
11%
Cancer Vaccination
11%
Therapeutic Vaccine
11%
CTL Response
11%
Tumor-related Genes
11%
Vaccine Therapy
11%
Ex Vivo Method
11%
Medicine and Dentistry
Prostate Cancer
100%
Immunotherapy
100%
Dendritic Cell
100%
Adenovirus Vector
100%
Prostate Specific Membrane Antigen
100%
N (4 Methoxyphenylacetyl)dehydroalanine
55%
Ex Vivo
33%
Target Cell
22%
Antigen Presentation
22%
Protein Expression
11%
T Cell
11%
Intraperitoneal Drug Administration
11%
Prostate Tumor
11%
Adenoviridae
11%
Gamma Interferon
11%
Gene Therapy
11%
Prostate Cancer Cell Line
11%
Cancer Immunotherapy
11%
Tumor Antigen
11%
Specific Tumor
11%
Tumor Vaccine
11%
Tumor Gene
11%
Cancer Immunization
11%
Immunology and Microbiology
Dendritic Cell
100%
Immunotherapy
100%
Adenovirus Vector
100%
Prostate Specific Membrane Antigen
100%
Target Cell
22%
Antigen Presentation
22%
Protein Expression
11%
T Cell
11%
Mouse Model
11%
Interferon Gamma
11%
Adenoviridae
11%
Prostate Cancer Cell Line
11%
MHC Class I
11%
Cancer Immunotherapy
11%
Tumor Antigen
11%
Tumor Vaccine
11%
Tumor Gene
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Adenovirus Vector
100%
Immunotherapy
100%
Prostate Specific Membrane Antigen
100%
N (4 Methoxyphenylacetyl)dehydroalanine
55%
Mouse Model
11%
Malignant Neoplasm
11%
Neoplasm
11%
Tumor Antigen
11%
Intraperitoneal Injection
11%
Adenoviridae
11%
Gamma Interferon
11%
Prostate Tumor
11%
Tumor Vaccine
11%
Biochemistry, Genetics and Molecular Biology
Adenovirus Vector
100%
Dendritic Cell
100%
Target Cell
40%
Antigen Presentation
40%
Cancer Cell
20%
Mouse Model
20%
Protein Expression
20%
T Cell
20%
Adenoviridae
20%
Gene Therapy
20%
Tumor Antigen
20%
Cancer Immunotherapy
20%
MHC Class I
20%
Interferon Gamma
20%